Use of C-reactive protein for prediction of sinus rhythm maintenance after pharmacologic cardioversion in patients with Metabolic Syndrome

1. Tanner RM, Baber U, Carson AP, et al. Association of the metabolic syndrome with atrial fibrillation among United States adults (from the Reasons for Geographic and Racial Differences in Stroke [REGARDS] Study). Am J Cardiol 2011;108:227–232. Tanner RM Baber U Carson AP . Association of the metabolic syndrome with atrial fibrillation among United States adults (from the Reasons for Geographic and Racial Differences in Stroke [REGARDS] Study) . Am J Cardiol 2011 ; 108 : 227 – 232 . Search in Google Scholar

2. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial Fibrilation: Epidemiology, pathoph- ysiology and clinical outcomes. Circ Res 2017;120:1501-17. Staerk L Sherer JA Ko D Benjamin EJ Helm RH. Atrial Fibrilation: Epidemiology, pathoph- ysiology and clinical outcomes . Circ Res 2017 ; 120 : 1501 - 17 . Search in Google Scholar

3. Nattel S, Harada M. Atrial remodeling and atrial fibrillation:recent advances and translational perspectives. J Am Coll Cardiol 2014;63:2335-45. Nattel S Harada M. Atrial remodeling and atrial fibrillation:recent advances and translational perspectives . J Am Coll Cardiol 2014 ; 63 : 2335 - 45 . Search in Google Scholar

4. Disertori M, Lombardi F, Barlera S, et al. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. Am Heart J 2011;162:382–9. Disertori M Lombardi F Barlera S . Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial . Am Heart J 2011 ; 162 : 382 – 9 . Search in Google Scholar

5. Wu N, Xu B, Xiang Y, et al. Association of inflammatory factors with occurrence and recurrence with atrial fibrillation:a meTanalysis. Int J Cardiol 2013;169:62-72. Wu N Xu B Xiang Y . Association of inflammatory factors with occurrence and recurrence with atrial fibrillation:a meTanalysis . Int J Cardiol 2013 ; 169 : 62 - 72 . Search in Google Scholar

6. Guo Y, Lip GY. Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012;60 (22):2263–70. Guo Y Lip GY. Apostolakis S. Inflammation in atrial fibrillation . J Am Coll Cardiol 2012 ; 60 ( 22 ): 2263 – 70 . Search in Google Scholar

7. Barassi A, Pezzilli R, Morselli-Labate AM, et al. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function. Can J Cardiol 2012;28(5):537-41. Barassi A Pezzilli R Morselli-Labate AM . Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function . Can J Cardiol 2012 ; 28 ( 5 ): 537 - 41 . Search in Google Scholar

8. Tong Liu, Guangping Li, Lijian Li, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2006;12:042. Liu Tong Li Guangping Li Lijian Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis . J Am Coll Cardiol 2006 ; 12 : 042 . Search in Google Scholar

9. Yo CH, Lee SH, Chang SS, Lee MC, Lee CC. Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis. BMJ Open 2014;20;4. Yo CH Lee SH Chang SS Lee MC Lee CC. Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis . BMJ Open 2014 ; 20 ; 4 . Search in Google Scholar

10. Yu L, Jian Z, Tao L, Zongtao Y, Yan JJ, Han Z, et al. The systemic-immune-inflammation index predicts the recurrence of atrial fibrillation after cryomaze concomitant with mitral valve surgery. BMC Cardiovascular Disorder 2022;22(45). Yu L Jian Z Tao L Zongtao Y Yan JJ Han Z . The systemic-immune-inflammation index predicts the recurrence of atrial fibrillation after cryomaze concomitant with mitral valve surgery . BMC Cardiovascular Disorder 2022 ; 22 ( 45 ). Search in Google Scholar

11. Hidrics G, Potparo T, Nikolaos D, Arbelo EJ, Bax J, Blomstron-Ludgvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. EHJ 2021;42(5):373-498. Hidrics G Potparo T Nikolaos D Arbelo EJ Bax J Blomstron-Ludgvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC . EHJ 2021 ; 42 ( 5 ): 373 - 498 . Search in Google Scholar

12. The seventh report of Joint National Committee on Prevention, Detection, Evaluation and treatment of Hight Blood Pressure. JAMA 2003;289:2550-72. The seventh report of Joint National Committee on Prevention, Detection , Evaluation and treatment of Hight Blood Pressure . JAMA 2003 ; 289 : 2550 - 72 . Search in Google Scholar

13. America Diabetes Association. Standards for medical care for patient with diabetes mellitus. Diabetes Care 2002;25(Suppl 1):S33-S49. America Diabetes Association . Standards for medical care for patient with diabetes mellitus . Diabetes Care 2002 ; 25 (Suppl 1):S33-S49. Search in Google Scholar

14. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention, and National Heart, Lung, and Blood Institute. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–45. Alberti KG Eckel RH Grundy SM . International Diabetes Federation Task Force on Epidemiology and Prevention, and National Heart, Lung, and Blood Institute. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity . Circulation 2009 ; 120 : 1640 – 45 . Search in Google Scholar

15. Center for disease control/American Heart association Workshop on inflammatory Markers, and Cardiovascular Disease: Application to clinical and public health practice: Atalanta, March 14-15, 2002. Atlanta, Ga. Centers for Disease Control and Prevention: 2002. Center for disease control/American Heart association Workshop on inflammatory Markers, and Cardiovascular Disease : Application to clinical and public health practice: Atalanta, March 14-15, 2002 . Atlanta, Ga . Centers for Disease Control and Prevention : 2002 . Search in Google Scholar

16. Lang RM, Badano LP, Mor-Avi, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Amer Soc Echocardio 2015;28(1):1–39. Lang RM Badano LP Mor-Avi . Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging . J Amer Soc Echocardio 2015 ; 28 ( 1 ): 1 – 39 . Search in Google Scholar

17. Gibson CM, Basto AN, Howard ML. Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence. Annals Pharmacotherapy 2018. Gibson CM Basto AN Howard ML. Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence . Annals Pharmacotherapy 2018 . Search in Google Scholar

18. Zarauza J, Rodriguez Lera MJ, Farinas Alvarez C, et al. Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion. Rev Esp Cardiol 2006;59:125-129. Zarauza J Rodriguez Lera MJ Farinas Alvarez C . Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion . Rev Esp Cardiol 2006 ; 59 : 125 - 129 . Search in Google Scholar

19. Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 2006;108:346-353. Watanabe E Arakawa T Uchiyama T Kodama I Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion . Int J Cardiol 2006 ; 108 : 346 - 353 . Search in Google Scholar

20. Wazni O, Martin DO, Marrouche NF, et al. C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart 2005;91:1303-1305. Wazni O Martin DO Marrouche NF . C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion . Heart 2005 ; 91 : 1303 - 1305 . Search in Google Scholar

21. Korantzopoulos P, Kolettis TM, Kountouris E, Siogas K, Goudevenos JA. Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation: Is there an association with early recurrence rates? Int J Clin Pract 2005;59:881-885. Korantzopoulos P Kolettis TM Kountouris E Siogas K Goudevenos JA. Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation: Is there an association with early recurrence rates? Int J Clin Pract 2005 ; 59 : 881 - 885 . Search in Google Scholar

22. Cosgrave J, Foley JB, Bahadur K, Bennett K, Crean P, Walsh MJ. Inflammatory markers are not associated with outcomes following elective external cardioversion. Int J Cardiol 2006;110:373-377. Cosgrave J Foley JB Bahadur K Bennett K Crean P Walsh MJ. Inflammatory markers are not associated with outcomes following elective external cardioversion . Int J Cardiol 2006 ; 110 : 373 - 377 . Search in Google Scholar

23. Schnabel RB, Larson MG, Yamamoto JF, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 2010;121 (2):200–7. Schnabel RB Larson MG Yamamoto JF . Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community . Circulation 2010 ; 121 ( 2 ): 200 – 7 . Search in Google Scholar

24. Jani Y, Haxhirexha K, Pocesta B, et al. Impact of Inflammation on Atrial Fibrillation in patients with Metabolic Syndrome. J Cardiology Interventions 2021;2(01):1-8. Jani Y Haxhirexha K Pocesta B . Impact of Inflammation on Atrial Fibrillation in patients with Metabolic Syndrome . J Cardiology Interventions 2021 ; 2 ( 01 ): 1 - 8 . Search in Google Scholar

25. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012;60:2263–2270. Guo Y Lip GY Apostolakis S. Inflammation in atrial fibrillation . J Am Coll Cardiol 2012 ; 60 : 2263 – 2270 . Search in Google Scholar

26. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96(4):1180–4. Frustaci A Chimenti C Bellocci F Morgante E Russo MA Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation . Circulation 1997 ; 96 ( 4 ): 1180 – 4 . Search in Google Scholar

27. Hadi AR, Alawi A, Wael AL & Jassim M. Inflammatory cytokines and atrial fibrillation: current and prospective views. Journal of Inflammation Research. 2010:75-97. Hadi AR Alawi A Wael AL & Jassim M. Inflammatory cytokines and atrial fibrillation: current and prospective views . Journal of Inflammation Research . 2010 : 75 - 97 . Search in Google Scholar

28. Tieleman RG, Van Gelder IC, Crijns HGJM, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998;31:167-173. Tieleman RG Van Gelder IC Crijns HGJM . Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998 ; 31 : 167 - 173 . Search in Google Scholar

29. Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Amer Coll Cardio 2014;63(22):2335–2345. Nattel S Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives . J Amer Coll Cardio 2014 ; 63 ( 22 ): 2335 – 2345 . Search in Google Scholar

30. Motoc A, Abugattas JP, Roosens B, Scheirlynck E, Heyndrickx B, de Asmundis C, et al. Left atrium remodeling predicts late recurrence of paroxysmal atrial fibrillation after second generation cryoballoon ablation. Cardiovascular Ultrasound 2018;25(19):16-19. Motoc A Abugattas JP Roosens B Scheirlynck E Heyndrickx B de Asmundis C . Left atrium remodeling predicts late recurrence of paroxysmal atrial fibrillation after second generation cryoballoon ablation . Cardiovascular Ultrasound 2018 ; 25 ( 19 ): 16 - 19 . Search in Google Scholar

31. Benditt DG, Williams JH, Jim J. Maintenance of sinus rhythm with oral d, l-sotalol therapy in patients with symptomatic atrial fibrillation and/or flutter. D, l-Sotalol Atrial Fibrillation/Flutter Group. Am J Cardiol 1999;84:270–277. Benditt DG Williams JH Jim J. Maintenance of sinus rhythm with oral d, l-sotalol therapy in patients with symptomatic atrial fibrillation and/or flutter. D, l-Sotalol Atrial Fibrillation/Flutter Group . Am J Cardiol 1999 ; 84 : 270 – 277 . Search in Google Scholar

32. Coplen SE, Antman EM, Berkis JA. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized trials. Circulation 1990;82:1106–1116. Coplen SE Antman EM Berkis JA. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized trials . Circulation 1990 ; 82 : 1106 – 1116 . Search in Google Scholar

33. Letsas KP, Weber R, Burkle G, Mihas CC, Minners J, Kalusche D, Arentz T. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace. 2009;11(2):158–63. Letsas KP Weber R Burkle G Mihas CC Minners J Kalusche D Arentz T. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation . Europace . 2009 ; 11 ( 2 ): 158 – 63 . Search in Google Scholar

34. Panagiotis K, Konstantinos P, Letsas F, Gary T, Nikolaos F, et al. Inflammation and atrial fibrillation:Acomprehesive review. J Arrhyth 2018. Panagiotis K Konstantinos P Letsas F Gary T Nikolaos F . Inflammation and atrial fibrillation:Acomprehesive review . J Arrhyth 2018 . Search in Google Scholar

35. Korantzopoulos P, Kolettis TM, Kountouris E, Siogas K, Goudevenos JA. Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates? Int J Clin Pract 2005 Aug;59(8):881-5. Korantzopoulos P Kolettis TM Kountouris E Siogas K Goudevenos JA. Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates? Int J Clin Pract 2005 Aug ; 59 ( 8 ): 881 - 5 . Search in Google Scholar